Overview

Quality Care

As an accredited facility by the American College of Surgeons’ Commission on Cancer, the hospital participates in collecting data regarding cancer patients diagnosed and treated at our facility. These quality measures are endorsed by the National Quality Forum. In the tables below our data is compared to other facilities in Illinois and nationally. This comparative data is made possible through the Commission on Cancer’s National Cancer Data Base.

The Kishwaukee Hospital Cancer Committee is pleased to present the following quality reports for data collected on care provided in 2015, the most recent available data.

Breast Cancers Diagnosed 2015

Image or palpation-guided needle biopsy to the primary site is performed to establish diagnosis of breast cancer.

	Performance Rate
Cancer Center at Kishwaukee Hospital	92.7%
CoC Benchmark	80%
My State (Illinois)	94.2%
All CoC Approved Programs	92.2%

Colon Cancers Diagnosed in 2015

At least 12 regional lymph nodes are removed and pathologically examined for resected colon cancer.

	Performance Rate
Cancer Center at Kishwaukee Hospital	87.5%
CoC Benchmark	85%
My State (Illinois)	93.6%
All CoC Approved Programs	92.2%

Lung Cancers Diagnosed in 2015

Systemic chemotherapy is administered within 4 months to day preoperatively or day of surgery to 6 months postoperatively, or it is recommended for surgically resected cases with pathologic lymph node-positive (pN1) and (pN2) NSCLC.

	Performance Rate
Cancer Center at Kishwaukee Hospital	100%
CoC Benchmark	85%
My State (Illinois)	93.8%
All CoC Approved Programs	91.5%

Surgery is not the first course of treatment for cN2, M0 lung cases.

	Performance Rate
Cancer Center at Kishwaukee Hospital	100%
CoC Benchmark	85%
My State (Illinois)	93.3%
All CoC Approved Programs	92.5%

Rectal Cancers Diagnosed in 2015

Preoperative chemo and radiation are administered for clinical AJCC T3N0, T4N0, or Stage III; or Postoperative chemo and radiation are administered within 180 days of diagnosis for clinical AJCC T102N0 with pathologic AJCC T3N0, T4N0, or Stage III; or treatment is recommended; for patients under the age of 80 receiving resection for rectal cancer.

	Performance Rate
Cancer Center at Kishwaukee Hospital	100.0%
CoC Benchmark	85%
My State (Illinois)	89.9%
All CoC Approved Programs	87.8%